NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Larppis, thanks for the update on the poly ICLC trial.

The Poly-ICLC trial has been going for 12 years now: https://clinicaltrials.gov/ct2/show/NCT01204684
The slide we've seen showed 50% survival rate at 100 months. And I believe ATLinsider said he's seen a More recent one showing 50% at 120 months.

Looks like vaccine+Keytruda is better with about 60% survival at 2 years and median not reached.

Now let’s see what vaccine+Keytruda +poly ICLC or another adjuvant can do to that efficacy rate!

Cure for most? Just wondering…